These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35389487)

  • 21. Replacement of saturated with unsaturated fats had no impact on vascular function but beneficial effects on lipid biomarkers, E-selectin, and blood pressure: results from the randomized, controlled Dietary Intervention and VAScular function (DIVAS) study.
    Vafeiadou K; Weech M; Altowaijri H; Todd S; Yaqoob P; Jackson KG; Lovegrove JA
    Am J Clin Nutr; 2015 Jul; 102(1):40-8. PubMed ID: 26016869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disrupted fatty acid distribution in HDL and LDL according to apolipoprotein E allele.
    Dang TM; Conway V; Plourde M
    Nutrition; 2015 Jun; 31(6):807-12. PubMed ID: 25933487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
    Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
    Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of diets rich in either saturated fat or n-6 polyunsaturated fatty acids and supplemented with long-chain n-3 polyunsaturated fatty acids on plasma lipoprotein profiles.
    Dias CB; Amigo N; Wood LG; Correig X; Garg ML
    Eur J Clin Nutr; 2017 Nov; 71(11):1297-1302. PubMed ID: 28488685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized placebo-controlled intervention with n-3 LC-PUFA-supplemented yoghurt: effects on circulating eicosanoids and cardiovascular risk factors.
    Dawczynski C; Massey KA; Ness C; Kiehntopf M; Stepanow S; Platzer M; Grün M; Nicolaou A; Jahreis G
    Clin Nutr; 2013 Oct; 32(5):686-96. PubMed ID: 23332800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial.
    Kastelein JJ; Maki KC; Susekov A; Ezhov M; Nordestgaard BG; Machielse BN; Kling D; Davidson MH
    J Clin Lipidol; 2014; 8(1):94-106. PubMed ID: 24528690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride levels.
    Berge K; Musa-Veloso K; Harwood M; Hoem N; Burri L
    Nutr Res; 2014 Feb; 34(2):126-33. PubMed ID: 24461313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. n-3 PUFA esterified to glycerol or as ethyl esters reduce non-fasting plasma triacylglycerol in subjects with hypertriglyceridemia: a randomized trial.
    Hedengran A; Szecsi PB; Dyerberg J; Harris WS; Stender S
    Lipids; 2015 Feb; 50(2):165-75. PubMed ID: 25403919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short communication: effects of omega-3 fatty acids on triglycerides and high-density lipoprotein subprofiles in HIV-infected persons with hypertriglyceridemia.
    Paranandi A; Asztalos BF; Mangili A; Kuvin J; Gerrior J; Sheehan H; Skinner SC; Tang AM; Wanke CA
    AIDS Res Hum Retroviruses; 2014 Aug; 30(8):800-5. PubMed ID: 24988179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia.
    Morton AM; Furtado JD; Lee J; Amerine W; Davidson MH; Sacks FM
    J Clin Lipidol; 2016; 10(6):1442-1451.e4. PubMed ID: 27919362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women.
    Furusyo N; Ai M; Okazaki M; Ikezaki H; Ihara T; Hayashi T; Hiramine S; Ura K; Kohzuma T; Schaefer EJ; Hayashi J
    Atherosclerosis; 2013 Dec; 231(2):238-45. PubMed ID: 24267234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia.
    Maki KC; Bays HE; Dicklin MR; Johnson SL; Shabbout M
    J Clin Lipidol; 2011; 5(6):483-92. PubMed ID: 22108152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial.
    Dunbar RL; Nicholls SJ; Maki KC; Roth EM; Orloff DG; Curcio D; Johnson J; Kling D; Davidson MH
    Lipids Health Dis; 2015 Sep; 14():98. PubMed ID: 26328624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
    Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
    JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omega 6 fatty acids for the primary prevention of cardiovascular disease.
    Al-Khudairy L; Hartley L; Clar C; Flowers N; Hooper L; Rees K
    Cochrane Database Syst Rev; 2015 Nov; (11):CD011094. PubMed ID: 26571451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-sectional and longitudinal associations of circulating omega-3 and omega-6 fatty acids with lipoprotein particle concentrations and sizes: population-based cohort study with 6-year follow-up.
    Mäntyselkä P; Niskanen L; Kautiainen H; Saltevo J; Würtz P; Soininen P; Kangas AJ; Ala-Korpela M; Vanhala M
    Lipids Health Dis; 2014 Feb; 13():28. PubMed ID: 24507090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial.
    Phelan N; O'Connor A; Kyaw Tun T; Correia N; Boran G; Roche HM; Gibney J
    Am J Clin Nutr; 2011 Mar; 93(3):652-62. PubMed ID: 21270384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study.
    Lai CQ; Corella D; Demissie S; Cupples LA; Adiconis X; Zhu Y; Parnell LD; Tucker KL; Ordovas JM
    Circulation; 2006 May; 113(17):2062-70. PubMed ID: 16636175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes.
    Mostad IL; Bjerve KS; Lydersen S; Grill V
    Eur J Clin Nutr; 2008 Mar; 62(3):419-29. PubMed ID: 17327864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nutritional effect on lipoproteins and their subfractions in patients with Psoriatic Arthritis: a 12-week randomized trial-the DIETA trial.
    Scherer D; Leite BF; Morimoto MA; Oliveira TL; Klemz BNC; Freitas RAMS; Pappiani C; Damasceno NRT; Pinheiro MM
    Adv Rheumatol; 2024 Jun; 64(1):47. PubMed ID: 38872193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.